Surface proteoglycans as mediators in bacterial pathogens infections

Frontiers in Microbiology

Volumn 7, Issue FEB, 2016, Pages

  García, Beatriz ^a   Merayo Lloves, Jesús ^a,b   Martin, Carla ^a   Alcalde, Ignacio ^a   Quirós, Luis M ^a   Vazquez, Fernando ^a,c  

^a UNIVERSITY OF OVIEDO   (Spain)

^b UNIVERSIDAD DE OVIEDO   (Spain)

^c Asturias University Hospital   (Spain)

Author keywords

Bacteria; Glycosaminoglycans; Host interaction; Infection; Proteoglycans

Indexed keywords

BETA1 INTEGRIN; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN BINDING PROTEIN; GLYCOPROTEIN D; GLYCOSAMINOGLYCAN; GLYCOSAMINOGLYCAN POLYSULFATE; HEPARIN; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METALLOPROTEINASE; PROTEOGLYCAN; SYNDECAN 1; SYNDECAN 4; VASCULOTROPIN;

ANTIBIOTIC RESISTANCE; BACTERIAL CONJUNCTIVITIS; BACTERIAL INFECTION; CHLAMYDIASIS; CHRONIC BRONCHITIS; CYSTIC FIBROSIS; DIGESTIVE SYSTEM ULCER; ENTEROCOCCAL INFECTION; GONORRHEA; GROUP A STREPTOCOCCAL INFECTION; GROUP B STREPTOCOCCAL MENINGITIS; HAEMOPHILUS INFECTION; HELICOBACTER INFECTION; HERPES SIMPLEX; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LISTERIOSIS; MENINGOCOCCOSIS; PATHOGENESIS; PERTUSSIS; PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN PROTEIN INTERACTION; REVIEW; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; TUBERCULOSIS; UPPER RESPIRATORY TRACT INFECTION;

EID: 84962069176     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.00220     Document Type: Review

References (96)

1. Armstrong, R. A. (2000). The microbiology of the eye. Ophthalmic Physiol. Opt. 20, 429-41
2. Baldassarri, L., Bertuccini, L., Creti, R., Filippini, P., Ammendolia, M. G., Koch, S., et al. (2005). Glycosaminoglycans mediate invasion and survival of Enterococcus faecalis into Macrophages. J. Infect. Dis. 191, 1253-1262. doi: 10.1086/428778
3. Barbier-Chassefière, V., Garcia-Filipe, S., Yue, X. L., Kerros, M. E., Petit, E., Kern, P., et al. (2009). Matrix therapy in regenerative medicine, a new approach to chronic wound healing. J. Biomed. Mater. Res. A 90, 641-647. doi: 10.1002/jbm.a.32124
4. Barlett, A. H., and Park, P. W. (2010). Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications. Expert. Rev. Mol. Med. 12:e5. doi: 10.1017/S1462399409001367
5. Bartlett, A. H., and Park, P. W. (2011). "Heparan sulfate proteoglycans in infection, "in Glycans in Diseases and Therapeutics, ed. M. S. G Paváo (Berlin: Springer Berlin Heidelberg), 31-62
6. Bastos, M. F., Albrecht, L., Kozlowski, E. O., Lopes, S. C., Blanco, Y. C., Carlos, B. C., et al. (2014). Fucosylated chondroitin sulfate inhibits Plasmodium falciparum cytoadhesion and merozoite invasion. Antimicrob. Agents Chemother. 58, 1862-1871. doi: 10.1128/AAC.00686-13
7. Becker, Y. (1996). "Chlamydia, "in Medical Microbiology, 4th Edn, ed. S. Baron (Galveston, TX: University of Texas Medical Branch at Galveston), 503-513
8. Brandely, M., Lagrange, P. H., and Hurtrel, B. (1986). Effects of suramin on the in vivo antimicrobial resistance against Listeria monocytogenes and Mycobacterium bovis (BCG) in mice. Clin. Exp. Immunol. 63, 118-126
9. Chang, Y. C., Wang, Z., Flax, L. A., Xu, D., Esko, J. D., Nizet, V., et al. (2011). Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systems. PLoS Pathog. 7:e1002082. doi: 10.1371/journal.ppat.1002082
10. Chen, L., and Hazlett, L. D. (2001). Human corneal epithelial extracellular matrix perlecan serves as a site for Pseudomonas aeruginosa binding. Curr. Eye Res. 22, 19-27. doi: 10.1076/ceyr.22.1.19.6973
11. Chen, X. E., Ling, P., Duan, R., and Zhang, T. (2012). Effects of heparosan and heparin on the adhesion and biofilm formation of several bacteria in vitro. Carbohydr. Polym. 88, 1288-1292. doi: 10.1016/j.carbpol.2012.02.006
12. Chen, Y., Götte, M., Liu, J., and Park, P. W. (2008). Microbial subversion of heparan sulfate proteoglycans. Mol. Cells 26, 415-426
13. Chen, Y., Hayashida, A., Bennett, A. E., Hollingshead, S. K., and Park, P. W. (2007). Streptococcus pneumoniae sheds syndecan-1 ectodomains through ZmpC, a metalloproteinase virulence factor. J. Biol. Chem. 882, 159-167. doi: 10.1074/jbc. M608542200
14. Clegg, D. O., Reda, D. J., Harris, C. L., Klein, M. A., O'Dell, J. R., Hooper, M. M., et al. (2006). Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N. Engl. J. Med. 354, 795-808. doi: 10.1056/NEJMoa052771
15. Dasaraju, P. V., and Liu, C. (1996). "Infections of the respiratory system, "in Medical Microbiology, 4th Edn, Chap. 93, ed. S. Baron (Galveston, TX: University of Texas Medical Branch at Galveston)
16. de Vries, F. P., Cole, R., Dankert, J., Frosch, M., and van Putten, J. P. (1998). Neisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors. Mol. Microbiol. 27, 1203-1212. doi: 10.1046/j.1365-2958.1998.00763.x
17. Esko, J. D., Kimata, K., and Lindahl, U. (2009). "Proteoglycans and sulfated glycosaminoglycans, "in Essentials of Glycobiology, eds A. Varki, R. D. Cummings, and J. D. Esko (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press), 229-248
18. Fechtner, T., Stallmann, S., Moelleken, K., Meyer, K. L., and Hegemann, J. H. (2013). Characterization of the interaction between the chlamydial adhesion OmcB and the human host cell. J. Bacterial. 195, 5323-5333. doi: 10.1128/JB.00780-13
19. Ferro, V., Dredge, K., Liu, L., Hammond, E., Bytheway, I., Li, C., et al. (2007). PI-88 and novel heparan sulfate mimetics inhibit angiogenesis. Semin. Throm. Hemost. 33, 557-568. doi: 10.1055/s-2007-982088
20. Finney, L. J., Ritchie, A., Pollard, E., Johnston, S. L., and Mallia, P. (2014). Lower airway colonization and inflammatory response in COPD: a focus on Haemophilus influenzae. Int. J. Chron. Obstruct. Pulmon Dis. 9, 1119-1132. doi: 10.2147/COPD.S54477
21. Fitton, J. H. (2011). Therapies from fucoidan; multifunctional marine polymers. Mar. Drugs 9, 1731-1760. doi: 10.3390/md9101731
22. Fleiszig, S. M., and Evans, D. J. (2002). The pathogenesis of bacterial keratitis: studies with Pseudomonas aeruginosa. Clin. Exp. Optom. 85, 271-278. doi: 10.1111/j.1444-0938.2002.tb03082.x
23. Frick, I. M., Schmidtchen, A., and Sjöbring, U. (2003). Interactions between M proteins of Streptococcus pyogenes and glycosaminoglycans promote bacterial adhesion to host cells. Eur. J. Biochem. 270, 2303-2311. doi: 10.1046/j.1432-1033.2003.03600.x
24. Gandhi, N. S., and Mancera, R. L. (2008). The structure of glycosaminoglycans and their interactions with proteins. Chem. Biol. Drug Des. 72: 455-482. doi: 10.1111/j.1747-0285.2008.00741.x
25. García, B., Fernández-Vega, I., García-Suárez, O., Castañón, S., and Quirós, L. M. (2014). The role of heparan sulfate proteoglycans in bacterial infections. J. Med. Microb. Diagn. 3:157
26. Garton, K. J., Gough, P. J., and Raines, E. W. (2006). Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J. Leukoc. Biol. 79, 1105-1116. doi: 10.1189/jlb.0106038
27. Guzman-Murillo, M. A., Ruiz-Bustos, E., Ho, B., and Ascencio, F. (2001). Involvement of the heparan sulphate-binding proteins of Helicobacter pylori in its adherence to HeLa S3 and Kato III cell lines. J. Med. Microbiol. 50, 320-329. doi: 10.1099/0022-1317-50-4-320
28. Hannah, J. H., Menozzi, F. D., Renauld, G., Locht, C., and Brennan, M. J. (1994). Sulfated glycoconjugate receptors for the Bordetella pertussis adhesin filamentous hemagglutinin (FHA) and mapping of the heparin-binding domain on FHA. Infect. Immun. 62, 5010-5019
29. Harris, N., Kogan, F. Y., Il'kova, G., Juhas, S., Lahmy, O., Gregor, Y. I., et al. (2014). Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties. Biochim. Biophys. Acta 1840, 245-254. doi: 10.1016/j.bbagen.2013.09.023
30. Hauck, C. R., and Ohlsen, K. (2006). Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. Curr. Opin. Microbiol. 9, 5-11. doi: 10.1016/j.mib.2005.12.002
31. Hayashida, A., Amano, S., and Park, P. W. (2011). Syndecan-1 promotes Staphylococcus aureus corneal infection by counteracting neutrophil-mediated host defense. J. Biol. Chem. 286, 3288-3297. doi: 10.1074/jbc. M110.185165
32. Henrich, M., Gruss, M., and Weigand, M. A. (2010). Sepsis-induced degradation of endothelial glycocalix. Sci. World J. 10, 917-923. doi: 10.1100/tsw.2010.88
33. Henry-Stanley, M. J., Hess, D. J., Erickson, E. A., Garni, R. M., and Wells, C. L. (2003). Role of heparan sulfate in interactions of Listeria monocytogenes with enterocytes. Med. Microbiol. Immunol. 192, 107-115
34. Henry-Stanley, M. J., Hess, D. J., Erlandsen, S. L., and Wells, C. L. (2005). Ability of the heparan sulfate proteoglycan syndecan-1 to participate in bacterial translocation across the intestinal epithelial barrier. Shock 24, 571-576. doi: 10.1097/01.shk.0000184286.95493.78
35. Hess, D. J., Henry-Stanley, M. J., Erlandsen, S. L., and Wells, C. L. (2006). Heparan sulfate proteoglycans mediate Staphylococcus aureus interactions with intestinal epithelium. Med. Microbiol. Immunol. 195, 133-141. doi: 10.1007/s00430-005-0007-5
36. Hollingshead, S. K., and Briles, D. E. (2001). Streptococcus pneumoniae: new tools for an old pathogen. Curr. Opin. Microbiol. 4, 71-77. doi: 10.1016/S1369-5274(00)00167-3
37. Huang, N., Wu, M. Y., Zheng, C. B., Zhu, L., Zhao, J. H., and Zheng, Y. T. (2013). The depolymerized fucosylated chondroitin sulfate from sea cucumber potently inhibits HIV replication via interfering with virus entry. Carbohydr. Res. 380, 64-69. doi: 10.1016/j.carres.2013.07.010
38. Ikeda, Y., Charef, S., Ouidja, M. O., Barbier-Chassefière, V., Sineriz, F., Duchesnay, A., et al. (2011). Synthesis and biological activities of a library of glycosaminoglycans mimetic oligosaccharides. Biomaterials 32, 769-776. doi: 10.1016/j.biomaterials.2010.09.043
39. Kamhi, E., Joo, E. J., Dordick, J. S., and Linhardt, R. J. (2013). Glycosaminoglycans in infectious disease. Biol. Rev. Camb. Philos. Soc. 88, 928-943. doi: 10.1111/brv.12034
40. Kim, J. H., Jiang, S., Elwell, C. A., and Engel, J. N. (2012). Chlamydia trachomatis co-opts the FGF2 signaling pathway to enhance infection. PLoS Pathog. 7:e1002285. doi: 10.1371/journal.ppat.1002285
41. King, P. (2012). Haemophilus influenzae and the lung (Haemophilus and the lung). Clin. Transl. Med. 1:10. doi: 10.1186/2001-1326-1-10
42. King, S. J. (2010). Pneumococcal modification of host sugars: a major contributor to colonization of the human airway? Mol. Oral Microbiol. 25, 15-24. doi: 10.1111/j.2041-1014.2009.00564.x
43. Kogan, G., Soltés, L., Stern, R., and Gemeiner, P. (2007). Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol. Lett. 29, 17-25. doi: 10.1007/s10529-006-9219-z
44. Kühlewein, C., Rechner, C., Meyer, T. F., and Rudel, R. (2006). Low-phosphate-dependent invasion resembles a general way for Neisseria gonorrhoeae to enter host cells. Infect. Immun. 74, 4266-4273. doi: 10.1128/IAI.00215-06
45. Leong, J. M., Wang, H., Magoun, L., Field, J. A., Morrissey, P. E., Robbins, D., et al. (1998). Different classes of proteoglycans contribute to the attachment of Borrelia burgdorferi to cultured endothelial and brain cells. Infect. Immun. 66, 994-999
46. Li, B., Lu, F., Wei, X., and Zhao, R. (2008). Fucoidan: structure and bioactivity. Molecules 13, 1671-1695. doi: 10.3390/molecules13081671
47. Li, P., Sheng, J., Liu, Y., Li, J., Liu, J., and Wang, F. (2013). Heparosan-derived heparan sulfate/heparin-like compounds: one kind of potential therapeutic agents. Med. Res. Rev. 33, 665-692. doi: 10.1002/med.21263
48. Martín, R., Martín, C., Escobedo, S., Suárez, J. E., and Quirós, L. M. (2013). Surface glycosaminoglycans mediate adherence between HeLa cells and Lactobacillus salivarius Lv72. BMC Microbiol. 13:210. doi: 10.1186/1471-2180-13-210
49. McGeary, R. P., Bennett, A. J., Tran, Q. B., Cosgrove, K. L., and Ross, B. P. (2008). Suramin: clinical uses and structure-activity relationships. Mini Rev. Med. Chem. 8, 1384-1394. doi: 10.2174/138955708786369573
50. Menozzi, F. D., Pethe, K., Bifani, P., Soncin, F., Brennan, M. J., and Locht, C. (2002). Enhanced bacterial virulence through exploitation of host glycosaminoglycans. Mol. Microbiol. 43, 1379-1386. doi: 10.1046/j.1365-2958.2002.02841.x
51. Menozzi, F. D., Reddy, V. M., Cayet, D., Raze, D., Debrie, A. S., Dehouck, M. P., et al. (2006). Mycobacterium tuberculosis heparin-binding haemagglutinin adhesin (HBHA) triggers receptor-mediated transcytosis without altering the integrity of tight junctions. Microbes Infect. 8, 1-9. doi: 10.1016/j.micinf.2005.03.023
52. Misra, S., Hascall, V. C., Atanelishvili, I., Rodriguez, R. M., Markwald, R. R., Ghatak, S. (2015). Utilization of glycosaminoglycans/proteoglycans as carriers for targeted therapy delivery. Int. J. Cell Biol. 2015:537560. doi: 10.1155/2015/537560
53. Morens, D. M., and Fauci, A. S. (2013). Emerging infectious diseases: threats to human health and global stability. PLoS Pathog. 9:e1003467. doi: 10.1371/journal.ppat.1003467
54. Moulder, J. W. (1991). Interaction of chlamydiae and host cells in vitro. Microbiol. Rev. 55, 143-190
55. Nam, E. J., and Park, P. W. (2012). Shedding of cell membrane-bound proteoglycans. Methods Mol. Biol. 836, 291-305. doi: 10.1007/978-1-61779-498-8_19
56. Nautiyal, A., Patil, K. N., and Muniyappa, K. (2014). Suramin is a potent and selective inhibitor of Mycobacterium tuberculosis RecA protein and the SOS response: RecA as a potential target for antibacterial drug discovery. J. Antimicrob. Chemother. 69, 1834-1843. doi: 10.1093/jac/dku080
57. Nelson, A., Berkestedt, I., and Bodelsson, M. (2014). Circulating glycosaminoglycan species in septic shock. Acta Anaesthesiol. Scand. 58, 36-43. doi: 10.1111/aas.12223
58. Nelson, A., Berkestedt, I., Schmidtchen, A., Ljunggren, L., and Bodelsson, M. (2008). Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock 30, 623-627. doi: 10.1097/SHK.0b013e3181777da3
59. Noel, G. J., Love, D. C., and Mosser, D. M. (1994). High-molecular-weight proteins of nontypeable Haemophilus influenzae mediates bacterial adhesion to cellular proteoglycans. Infect. Immun. 62, 4028-4033
60. O'Callaghan, R. J., Engel, L. S., Hobden, J. A., Callegan, M. C., Green, L. C., and Hill, J. M. (1996). Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence. Invest. Ophthalmol. Vis. Sci. 37, 534-543
61. Odenbreit, S., Puls, J., Sedlmaier, B., Gerland, E., Fischer, W., and Hass, H. (2000). Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287, 1497-1500. doi: 10.1126/science.287.5457.1497
62. Palframan, S. L., Kwok, T., and Gabriel, K. (2012). Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis. Front. Cell. Infect. Microbiol. 2:92. doi: 10.3389/fcimb.2012.00092
63. Pizarro-Cerdá, J., and Cossart, P. (2006). Subversion of cellular functions by Listeria monocytogenes. J. Pathol. 208, 215-223. doi: 10.1002/path.1888
64. Pomin, V. H. (2015). A dilemma in the glycosaminoglycan-based therapy: synthetic or naturally unique molecules? Med. Res. Rev. 35, 1195-1219. doi: 10.1002/med.21356
65. Prestwich, G. D., and Kennedy, T. P. (2011). Methods for Treating or Preventing the Spread of Cancer Using Semi-synthetic Glycosaminoglycosan Ethers, U.S. Patent Application No. 13/575, 069
66. Prestwich, G. D., Zhang, J., Kennedy, T. P., Rao, N. V. (2012). Alkylated Semi Synthetic Glycosaminoglycosan Ethers, and Methods for Making and Using Thereof, U.S. Patent No. 8, 329, 673. Washington, DC: U.S. Patent and Trademark Office
67. Rajilic-Stojanovic, M., Smidt, H., and de Vos, W. M. (2007). Diversity of the human gastrointestinal tract microbiota revisited. Environ. Microbiol. 9, 2125-2136. doi: 10.1111/j.1462-2920.2007.01369.x
68. Raman, R., Sasisekharan, V., and Sasisekharan, R. (2005). Structural insights into biological roles of protein-glycosaminoglycan interactions. Chem. Biol. 12, 267-277. doi: 10.1016/j.chembiol.2004.11.020
69. Reeves, E. P., Bergin, D. A., Murray, M. A., and McElvaney, N. G. (2011). The involvement of glycosaminoglycans in airway disease associated with cystic fibrosis. Sci. World J. 11, 959-971. doi: 10.1100/tsw.2011.81
70. Rudd, T. R., Hughes, A., Holman, J., Solari, V., Ferreira Ede, O., Domingues, R. M., et al. (2012). Heparan sulphate, its derivatives and analogues share structural characteristics that can be exploited, particularly in inhibiting microbial attachment. Braz. J. Med. Biol. Res. 45, 386-391
71. Rusnati, M., Oreste, P., Zoppetti, G., and Presta, M. (2005). Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discovery. Curr. Pharm. Des. 11, 2489-2499. doi: 10.2174/1381612054367553
72. Rusnati, M., and Urbinati, C. (2009). Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis. Curr. Pharm. Des. 15, 2946-2957. doi: 10.2174/138161209789058156
73. San Antonio, J., and Iozzo, R. (2001). Glycosaminoglycans: Structure and Biological Functions. Encyclopedia of Life Sciences. London: Nature Publishing Company
74. Sarrazin, S., Lamanna, W. C., and Esko, J. D. (2011). Heparan sulfate proteoglycans. Cold Spring Harb. Perspect. Biol. 3:a004952
75. Sava, I. G., Zhang, F., Toma, I., Theilacker, C., Li, B., Baumert, T. F., et al. (2009). Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cells. J. Biol. Chem. 284, 18194-18201. doi: 10.1074/jbc. M901460200
76. Schmidtchen, A., Holst, E., Tapper, H., and Bjorck, L. (2003). Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth. Microb. Pathog. 34, 47-55. doi: 10.1016/S0882-4010(02)00197-3
77. Schuksz, M., Fuster, M. M., Brown, J. R., Crawford, B. E., Ditto, D. P., Lawrence, R., et al. (2008). Surfen, a small molecule antagonist of heparan sulfate. Proc. Natl. Acad. Sci. U.S.A. 105, 13075-13080. doi: 10.1073/pnas.0805862105
78. Souza-Fernandes, A. B., Pelosi, P., and Rocco, P. R. (2006). Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease. Crit. Care 10:237. doi: 10.1186/cc5069
79. Sugahara, K., and Kitagawa, H. (2002). Heparin and heparan sulfate biosynthesis. IUBMB Life 54, 163-175. doi: 10.1080/15216540214928
80. Taraktchoglou, M., Pacey, A. A., Turnbull, J. E., and Eley, A. (2001). Infectivity of Chlamydia trachomatis serovar LGV but not E is dependent on host cell heparan sulfate. Infect. Immun. 69, 968-976. doi: 10.1128/IAI.69.2.968-976.2001
81. Tonnaer, E. L., Hafmans, T. G., Van Kuppevelt, T. H., Sanders, E. A., Verweij, P. E., and Curfs, J. H. (2006). Involvement of glycosaminoglycans in the attachment of pneumococci to nasopharyngeal epithelial cells. Microbes Infect. 8, 316-322. doi: 10.1016/j.micinf.2005.06.028
82. Torella, M., Schettino, M. T., Salvatore, S., Serati, M., De Franciscis, P., and Colacurci, N. (2013). Intravesical therapy in recurrent cystitis: a multi-center experience. J. Infect. Chemother. 19, 920-925. doi: 10.1007/s10156-013-0609-6
83. Tuomanen, E., Rich, R., and Zak, O. (1987). Induction of pulmonary inflammation by components of the pneumococcal cell surface. Am. Rev. Respir. Dis. 135, 869-874. doi: 10.1164/arrd.1987.135.4.869
84. Twining, S. S., Kirschner, S. E., Mahnke, L. A., and Frank, D. W. (1993). Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Invest. Ophthalmol. Vis. Sci. 34, 2699-2712
85. van Wijk, X. M., Lawrence, R., Thijssen, V. L., van den Broek, S. A., Troost, R., van Scherpenzeel, M., et al. (2015). A common sugar-nucleotide-mediated mechanism of inhibition of (glycosamino) glycan biosynthesis, as evidenced by 6F-GalNAc (Ac3). FASEB J. 29, 2993-3002. doi: 10.1096/fj.14-264226
86. Venge, P., Pedersen, B., Håkansson, L., Hällgren, R. O. G. E. R., Lindblad, G., and Dahl, R. (1996). Subcutaneous administration of hyaluronan reduces the number of infectious exacerbations in patients with chronic bronchitis. Am. J. Respir. Crit. Care Med. 153, 312-316. doi: 10.1164/ajrccm.153.1.8542136
87. Virji, M. (2009). Ins and outs of microbial adhesion. Top. Curr. Chem. 288, 139-156. doi: 10.1007/128_2008_15
88. Wang, Y., Qing, J., Sun, Y., and Rao, Z. (2014). Suramin inhibits EV71 infection. Antiviral Res. 103, 1-6. doi: 10.1016/j.antiviral.2013.12.008
89. Willcox, M. D. (2007). Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optom. Vis. Sci. 84, 273-278. doi: 10.1097/OPX.0b013e3180439c3e
90. World Health Organization [WHO] (2011). Pertussis. Available at: http://www.who.int/immunization/topics/pertussis/en/[Accessed on 29 October 2015]
91. World Health Organization [WHO] (2013). Sexually Transmitted Infections (STIs). Available at: http://www.who.int/mediacentre/factsheets/fs110/en/[Accessed on 30 December 2015]
92. World Health Organization [WHO] (2014a). Antimicrobial Resistance: Global Report on Surveillance 2014. Available at: http://www.who.int/drugresistance/documents/surveillancereport/en/[Accessed on 27 October 2015]
93. World Health Organization [WHO] (2014b). The Top 10 Causes of Death. Available at: http://www.who.int/mediacentre/factsheets/fs310/en/[Accessed on 27 October 2015]
94. World Health Organization [WHO] (2015). Tuberculosis. Available at: http://www.who.int/mediacentre/factsheets/fs104/en/[Accessed on 30 October 2015]
95. Yazawa, S. (2014). Editorial comment to restoring the glycosaminoglycans layer in recurrent cystitis: experimental and clinical foundations. Int. J. Urol. 21, 769-769. doi: 10.1111/iju.12449
96. Young, E. (2008). The anti-inflammatory effects of heparin and related compounds. Thromb. Res. 122, 743-752. doi: 10.1016/j.thromres.2006.10.026